Interestingly, our results showed that UBE2O dramatically reduced the secretion of exosome-related PTRF, suggesting that an increase of UBE2O expression might be an approach to treat glioma and ccRCC. Here, UBE2O is linked to nonpapillary renal cell carcinoma.